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ABSTRACT: Ferritin-like molecules are unique to cellular iron
homeostasis because they can store iron at concentrations much
higher than those dictated by the solubility of Fe3+. Very little is
known about the protein interactions that deliver iron for
storage or promote the mobilization of stored iron from ferritinlike molecules. Here, we report the X-ray crystal structure of
Pseudomonas aeruginosa bacterioferritin (Pa-BfrB) in complex
with bacterioferritin-associated ferredoxin (Pa-Bfd) at 2.0 Å
resolution. As the ﬁrst example of a ferritin-like molecule in
complex with a cognate partner, the structure provides
unprecedented insight into the complementary interface that enables the [2Fe-2S] cluster of Pa-Bfd to promote hememediated electron transfer through the BfrB protein dielectric (∼18 Å), a process that is necessary to reduce the core ferric
mineral and facilitate mobilization of Fe2+. The Pa-BfrB−Bfd complex also revealed the ﬁrst structure of a Bfd, thus providing a
ﬁrst view to what appears to be a versatile metal binding domain ubiquitous to the large Fer2_BFD family of proteins and
enzymes with diverse functions. Residues at the Pa-BfrB−Bfd interface are highly conserved in Bfr and Bfd sequences from a
number of pathogenic bacteria, suggesting that the speciﬁc recognition between Pa-BfrB and Pa-Bfd is of widespread signiﬁcance
to the understanding of bacterial iron homeostasis.

■

INTRODUCTION
Iron is an essential nutrient needed as cofactor in respiration,
nitrogen ﬁxation, photosynthesis, and DNA synthesis and
repair.1,2 Iron acquisition, storage, and utilization are subject to
tight homeostatic regulation because the soluble Fe2+ can react
with O2 to form reactive oxygen species and the highly
insoluble Fe3+.3 The challenges presented to cells by the
chemical properties of iron have been largely answered in the
unique structure and function of ferritin and ferritin-like
molecules. These have nearly spherical and hollow structures
assembled from 24 subunits (∼450 kDa) where each subunit
consists of a four-helix bundle and a short C-terminal helix that
is nearly perpendicular to the bundle. The pivotal contributions
made by ferritin-like molecules to iron homeostasis are
manifested by their presence in all three domains of life with
remarkable conservation of structure and function despite very
low conservation in sequence (<20%).4,5 Three types of
ferritin-like molecules are present in bacteria: the ferritins
(Ftn), the bacterioferritins (Bfr), and the DNA binding
proteins from starved cells (Dps).2 Ftns and Bfrs are composed
of 24 subunits that assemble into a spherical protein with a
© 2012 American Chemical Society

hollow cavity approximately 8 nm in diameter where the iron
mineral is stored. Dps are composed of 12 subunits, which
assemble into a nearly spherical protein with a central cavity
approximately 4.5 nm diameter. A unique property of the
bacterioferritins, which only occur in bacteria and archaea,4 is
that they bind a heme molecule between two subunits (Figure
1a), so that the 24-mer protein consists of 12 subunit dimers
and 12 hemes (Figure 1b). The heme is buried deep below the
protein surface (∼13 Å) such that the heme propionates reach
into the interior cavity where the iron mineral is stored (Figure
1c).
Ferritin and ferritin-like molecules capture Fe2+, convert it to
Fe3+ at catalytic centers located in the middle of each subunit,
using O2 or H2O2 as oxidants, and store Fe3+ as a mineral in
their hollow cavities, eﬀectively concentrating Fe3+ to levels
orders of magnitude higher that those permitted by its low
solubility.6 When the nutrient is needed in metabolism, the
ferric mineral is solubilized by reducing it to Fe2+, which exits
Received: May 29, 2012
Published: July 19, 2012
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Figure 1. Structure of Pa BfrB (PDB 3IS7). (a) A subunit dimer and the intersubunit location of heme which is coordinated by a conserved
methionine in each of the subunits. (b) The biological assembly consisting of 12 subunit dimers and 12 heme molecules, viewed along a 4-fold pore
where a K+ ion (purple sphere) is bound. (c) A view of the large interior cavity where the iron mineral is stored, illustrating how heme molecules are
buried below the protein surface with the heme propionates extending into the interior cavity (heme is in green with O atomos in red and N atoms
in blue).

investigation suggested that Pa-Bfr is a heteropolymer
assembled from two diﬀerent subunits, α- and β-Bfr.23
Subsequent studies established the presence of two genes
encoding ferritin-like molecules (bf rA and bf rB) but suggested
that two distinct bacterioferritins (Pa-BfrA and Pa-BfrB) may
coexist.24 More recently, we showed that the product of bf rB is
a genuine bacterioferritin assembled from 24 identical subunits
and 12 heme molecules,25 whereas the product of bf rA, also
assembled from 24 identical subunits, does not bind heme and
is not a bacterioferritin but a bacterial ferritin, now termed PaFtnA.26 Hence, two distinct ferritins coexist in P. aeruginosa, a
bacterioferritin (Pa-BfrB) and a bacterial ferritin (Pa-FtnA).
In vitro reconstitution of Pa-BfrB with Pa-FPR, Pa-Bfd, and
NADPH enables heme-mediated electron transfer into the PaBfrB cavity and release of Fe2+. In the absence of Pa-Bfd, the
heme is not reduced, and iron is not mobilized from Pa-BfrB,10
indicating that Pa-Bfd mediates electrons between Pa-FPR and
Pa-BfrB. Similar experiments conducted with apo-Pa-Bfd
prepared in situ, however, showed that apo-Pa-Bfd also
stimulates the rapid mobilization of Fe2+ from Pa-BfrB,
suggesting the possibility that the role of apo-Bfd is to recruit
the reductase (Pa-FPR) to the Pa-BfrB surface.10 Thus,
although the interplay between BfrB, Bfd, and FPR is a unique
example of speciﬁc protein interactions regulating the function
of ferritin-like molecules, the particular roles played by Bfd and
FPR in the release of iron remain unclear. Herein we report the
crystal structure of the Pa-BfrB−Pa-Bfd complex, which reveals
a highly complementary interface that positions the [2Fe-2S]
cluster of Pa-Bfd in an ideal position to transfer electrons to the
heme in Pa-BfrB. The structure also provides a ﬁrst insight into
the Bfd fold, which appears to require a phosphate ion for
optimum stability, a ﬁnding that was exploited to prepare apoPa-Bfd and demonstrate that the [2Fe-2S] cluster must be
present in Pa-Bfd to support heme reduction and Fe2+
mobilization from Pa-BfrB.

the protein shell via channels formed in the 24-mer
assembly.5,7−9 The biological ligands or the protein−protein
interactions that enable electron transfer into the interior cavity
of eukaryotic ferritin to promote release of Fe2+ have thus far
remained mysterious. Studies of Escherichia coli and Pseudomonas aeruginosa Bfr suggest that recovery of iron from the Bfr
cavity requires speciﬁc protein−protein interactions to mediate
electrons into the Bfr core and promote Fe2+ release.10−12
Although the heme in Bfr is thought to mediate electrons
across the ∼20 Å protein shell,10,13,14 the fact that it is buried
deep below the surface (Figure 1c) has made it challenging to
understand how cognate partners may interact with Bfr and
how the electrons supplied via protein−protein interactions
reach the heme. Nevertheless, attaining atomic level understanding of the intermolecular interactions that enable ferritinlike molecules to maintain iron homeostasis in bacteria is
important because of the recent demonstration that bacterial
iron storage proteins are critical for the survival of pathogens in
the host and therefore may be attractive targets for
antimicrobial development.15
P. aeruginosa is a Gram negative opportunistic pathogen and
is the major pathogen responsible for the decline of lung
function and premature death in patients with cystic ﬁbrosis by
virtue of persistent infections that steadily destroy host
tissues.16,17 In P. aeruginosa and in E. coli the bf r gene is
contiguous to a gene dubbed bacterioferritin-associated
ferredoxin (bfd) for its proximity to bf r and the fact that its
product binds a [2Fe-2S] cluster.11,12,18,19 E. coli Bfd (Ec-Bfd)
binds to Ec-Bfr, which led several groups to suggest that Ec-Bfd
may function either as electron acceptor in the process of iron
uptake by Ec-Bfr or as electron donor in iron mobilization from
Ec-Bfr.11,12 This issue has been pursued in more detail in P.
aeruginosa,10 capitalizing on its known global genetic response
to high- or low-iron concentrations.20,21 Among the large
number of genes responding to low-iron stimulus, bfd is
strongly up-regulated, and a gene coding a ferredoxin reductase
(f pr) is also up-regulated, whereas bf rB is down-regulated. The
strong up-regulation of bfd under low-iron prompted us to
suggest that Pa-Bfd may participate in the mobilization of iron
from Pa-BfrB by mediating electrons from Pa-FPR to Pa-BfrB,
enabling reduction of the ferric mineral and the release of
Fe2+.10 Characterization of the proteins coded by the bfd, f pr,
and bf r genes in P. aeruginosa showed that Pa-FPR is a 29.4
kDa, NADPH-dependent ﬂavoprotein19,22 and Pa-Bfd is a 7.8
kDa protein that binds a [2Fe-2S] cluster.19 An early

■

EXPERIMENTAL PROCEDURES

Pa-BfrB and the C43S mutant of Pa-Bfd were prepared and puriﬁed as
reported previously.10 The C43S mutant is more stable to puriﬁcation
storage and manipulation but has the same spectroscopic and
functional properties of Pa-Bfd.10 Hence, in this report the C43S
mutant will be referred to as Pa-Bfd. The preparation of Pa-BfrB
containing ∼550 iron atoms per Pa-BfrB molecule and the
experiments conducted to measure iron release from Pa-BfrB were
carried out as described previously.10
13471
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Table 1. Crystallographic Data for Pa-BfrB−Bfd Reﬁned to
2.0 Å Resolution

Preparation of Apo-Bfd. A 0.54 mM solution of Pa-Bfd in 50
mM potassium phosphate (pH 7.0), 150 mM NaCl, and 5 mM DTT
was diluted 8 times in buﬀer 1, consisting of sodium acetate buﬀer
(150 mM, pH 5.5) 8 M urea, 150 mM NaCl, 5 mM tris(2carboxyethyl)phosphine (TCEP), and 3 mM N,N′-di-(2hydroxybenzyl)ethylenediamine-N,N′-diacetic acid (HBED). The
resultant solution was stirred continuously at room temperature for
70 min. Iron chelated by HBED was removed by dialysis against buﬀer
1 at room temperature. HBED was then removed by dialysis against
buﬀer 1 without the chelator, and the apo-protein was then dialyzed
against buﬀer 2 (200 mM potassium phosphate, 8 M urea, 5 mM
TCEP, pH 7.0) at room temperature. Refolding of apo-Bfd was carried
out in two steps by dialyzing the protein against buﬀer 2 containing 4
M urea at 4 °C and then against buﬀer 2 without urea at 4 °C.
Crystallization and X-ray Data Collection. Crystal growth
conditions were screened with solutions of Pa-BfrB (40 μM) in 100
mM potassium phosphate (pH 7.6) and 1 mM TCEP and Pa-Bfd (480
μM) in 50 mM potassium phosphate (pH 7.0), 150 mM NaCl, and 5
mM DTT. The solutions were combined to produce a mixture with a
12Bfd:1BfrB mole ratio. Equal volumes of protein and crystallant (1
μL) were equilibrated against 100 μL of the latter in sitting drop vapor
diﬀusion plates at 18 °C. Small prismatic crystals were obtained in 1−2
days with condition G8 (0.8 M Na/K hydrogen phosphate, pH 7.5) of
the Proplex HT screen (Molecular Dimensions). Crystals were
transferred to a fresh drop of 80% crystallization solution and 20%
glycerol before ﬂash freezing. Data were collected (λ = 1.0000 Å) at
the Advanced Photon Source beamline 17ID, Argonne National
Laboratories, using a Dectris Pilatus 6 M pixel array detector.
Structure Solution and Reﬁnement. Intensities were integrated
using XDS27 and the Laue class check, and data scaling were
performed with Aimless.28 The highest probability Laue class was 4/
mmm and space group P4212. The Matthew’s coeﬃcient (Vm)29 and
% solvent content were estimated to be 2.9 and 58.2% for 6 Pa-BfrB
subunits in the asymmetric unit. Structure solution was conducted by
molecular replacement with Phaser30 via the Phenix31 interface. All
space groups with 422 point symmetry were tested using a Pa-BfrB
dimer from a previously determined structure (PDB: 3IS7)25 as the
search model. The top solution, consisting of three-subunit dimers,
was obtained in the space group P4212, which was used from this point
forward. Following initial reﬁnement with Phenix, diﬀerence electron
density (Fo − Fc) consistent with Bfd molecules near the heme at the
interface of each BfrB subunit dimer was manually ﬁt to the model
using Coot,32 and the structure was reﬁned with Phenix. A second data
set was collected with the same crystal at the Fe edge (λ = 1.73769 Å),
and anomalous diﬀerence electron density maps were calculated to
conﬁrm the orientation of the Fe-S cluster in the Bfd molecules.
Structure validation was conducted with Molprobity,33 and the data
collection and reﬁnement statistics are in Table 1. There were no
amino acid outliers in the Ramachandran plot where 99.3% and 0.7%
resided in the favored and allowed regions, respectively.

BfrB−Bfd
Data Collection
unit cell parameters (Å, o)
space group
resolution (Å)a
wavelength (Å)
temperature (K)
observed reﬂections
unique reﬂections
<I/σ(I)>a
completeness (%)a
multiplicitya
Rmerge (%)a,b
Rmeas (%)a,d
Rpim (%)a,d
Reﬁnement
resolution (Å)
reﬂections (working/test)
Rfactor/Rfree (%)c
no. of atoms (BfrB/Bfd/Heme/Fe-S/
K+/Na+/phosphate/water)
Model Quality
rms deviations
bond lengths (Å)
bond angles (°)
average B factor (Å2)
all atoms
BfrB/Bfd
heme/Fe-S/K+/Na+/phosphate
water
coordinate error, max likelihood
(Å)
Ramachandran Plot
most favored (%)
additionally allowed (%)

a = 135.81, c = 200.89
P4212
200.89−2.00 (2.03−2.00)
1.0000
100
1 120 495
125 332
15.2 (3.0)
100 (100)
8.9 (9.2)
11.7 (80.5)
13.3 (90.3)
4.4 (29.6)
47.73−2.0
118 964/6294
15.2/18.3
7714/1087/258/12/3/6/5/1062

0.011
1.185
24.0
20.9/41.4
22.9/26.9/15.3/24.0/35.7
39.1
0.22

99.3
0.7

a

Values in parentheses are for the highest resolution shell. bRmerge =
∑hkl∑i |Ii(hkl) − <I(hkl)>|/∑hkl∑i Ii(hkl), where Ii(hkl) is the
intensity measured for the ith reﬂection and <I(hkl)> is the average
intensity of all reﬂections with indices hkl. cRfactor = ∑hkl ∥Fobs (hkl) | −
|Fcalc (hkl) ∥/∑hkl |Fobs (hkl)|; Rfree is calculated in an identical manner
using 5% of randomly selected reﬂections that were not included in the
reﬁnement. dRmeas = redundancy-independent (multiplicity-weighted)
R merge.52,53 Rpim = precision-indicating (multiplicity-weighted)
Rmerge.54,55

■

RESULTS AND DISCUSSION
Overall Structure of the Pa-BfrB−Bfd Complex. The
crystal structure of Pa-BfrB in complex with Pa-Bfd (Pa-BfrB−
Bfd) was determined at 2.0 Å resolution. The asymmetric unit
cell contains three BfrB subunit dimers, each associated with
electron density consistent with a Bfd molecule (Figure 2a).
Well-deﬁned electron density describes a molecule of Bfd
bound at the interface of each BfrB subunit dimer in the
asymmetric cell unit, above each of the heme molecules (Figure
2b,c). Hence, the biological assembly consists of a nearly
spherical 24-mer BfrB with 12 heme and 12 Bfd molecules
(Figure 2d). As observed in previous structures of Pa-BfrB,25
electron density greater than 3σ is observed in the 4-fold pores,
which was modeled as potassium ions (purple) based on
distances and coordination geometry. In addition, when sodium
ions were reﬁned at these sites, positive electron density was
observed, which suggest that assignment as potassium is most

likely correct. Barium and iron ions have also been observed in
4-fold pores of Azotobacter vinelandii Bfr, leading to the
suggestion that iron ions may traﬃc in and out of
bacterioferritin via 4-fold pores.34,35 In addition, and previously
not observed in other bacterioferritin structures, positive
electron density greater than 3σ is present at the B-pores of
Pa-BfrB in the BfrB−Bfd complex. This electron density was
successfully modeled as sodium ions (green) coordinated by
D34 from one of the subunits forming a B-pore and by D132
and T136 from another subunit related by crystallographic
symmetry. Reﬁnement as potassium ions or water molecules
resulted in negative and positive electron density at these sites,
respectively, which suggests that sodium ions are the most
probable choice. Fo − Fc omit maps of electron density present
in the 4-fold and B-pores are shown in Figure 2e,f, respectively.
The presence of sodium ions in B-pores is the ﬁrst structural
13472
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Figure 2. Structure of the Pa-BfrB−Bfd complex. (a) The asymmetric unit cell consisting of three BfrB subunit dimers, each associated with a Bfd
molecule (cyan); Fe-S atoms are represented as orange and yellow spheres, respectively; the heme molecules between each subunit dimer are shown
in green; potassium atoms in 4-fold pores are represented as purple spheres; and sodium atoms in the B pores as green spheres. (b) Fo − Fc omit
map contoured at 3σ showing the electron density (purple) of Bfd chain G. (c) View of a Bfd molecule (cyan) bound to the surface of a BfrB subunit
dimer above the heme, which is buried below the surface. (d) Biological assembly consisting of 12 Bfds bound to 12 BfrB subunit dimers. (e) View of
a 4-fold pore in which K+ (purple) is coordinated by Asn148 and Gln151. (f) View of a B-pore in which Na+ is coordinated by Asp34, Asp132, and
Thr136. The Fo − Fc omit maps for the K+ and Na+ ions contoured at 3σ are shown in green mesh and coordinated water molecules as red spheres.
(g) Superposition of Pa-BfrB (green) and Pa-BfrB−Bfd (magenta) structures showing the ferroxidase center ligands.

and Fe-S2− distances are 2.31 and 2.22 Å, respectively, which
are similar to those observed in structures of [2Fe-2S]containing proteins.
Bfd-like sequences are present in a number of bacteria
(Figure S1, Supporting Information). Four conserved cysteine
residues are organized in a unique C-X1-C-X31−32-C-X2-Carrangement in a peptide that at 73 residues long is ∼50
residues shorter than [2Fe-2S] ferredoxins from bacteria,
plants, fungi, and vertebrates. Hence, Bfd is a class of [2Fe2S] ferredoxin distinguishable from the others by its sequence
and spectroscopic properties.12 Search of the Pfam database37
shows that the Bfd sequence determines a large, manually
curated Pfam family, Fer2_BFD (PF04324), of single and
multiple domain proteins where the C-X1-C arrangement is
highly conserved and the C-X2-C arrangement is partially
conserved. The Fer2_BFD sequence is present in multidomain
enzymes and proteins with a variety of functions, such as
nitrate, nitrite, and sulﬁte reductases, FAD-dependent oxidoreductases, nitrogen ﬁxation (NifU) proteins, and copper and
mercury transport proteins. Structural alignment searches
conducted with I-COFACTOR,38 DALI,39 and PdBeFold40
strongly suggest that the Bfd fold has not been previously

evidence supporting the idea that B-pores in Bfr may serve as
conduits for ion traﬃc.36 The ferroxidase center in the structure
of the Pa-BfrB−Bfd complex is devoid of iron (magenta in
Figure 2g), and the ferroxidase ligands adopt conformations
identical to those observed in the empty ferroxidase center of
Pa-BfrB alone25 (green in Figure 2g).
The Bfd Fold. The structure of Pa-Bfd, revealed as part of
the structural determination of the Pa-BfrB−Bfd complex, is
the ﬁrst structure of a Bfd molecule. The fold, comprised of
helix−turn−helix, binds a [2Fe-2S] center via C-4, C-6, C-38,
and C-41, located in loops 1 and 3 (Figure 3a), which are
oriented nearly antiparallel to one another and supported by 3
α-helices. Loop 1 (L1) contains C-4 and C-6 and is followed by
a 3-turn helix (α-1). Loop 2 (L2) connects α-1 to the shortest
helix in the structure, the 2-turn α-2, which is followed by loop
3 (L3) containing C-38 and C-41. The longest helix in the
structure (α-3) spans from C-41 to Q-57, which is the last
residue for which electron density is observed. Anomalous
diﬀerence electron density maps obtained from data collected
at the Fe-edge allowed unambiguous identiﬁcation of the iron
atoms and placement of the [2Fe-2S] cluster (Figure 3b). The
average Fe-Fe distance is 2.85 Å, and the average Fe-S(Cys)
13473
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structure of Pa-Bfd is the ﬁrst example of a single domain
Fer2_BFD protein, and the structure of CopZ-NT appears to
be the only example of a multidomain Fer2_BFD protein,
although the structure describes only the 130-residue N′terminal domain. Taken together, the observations made from
sequence and structural alignments indicate that the Bfd fold is
a versatile metal-binding structural motif that has been
incorporated into a large number of Fer2_BFD proteins and
enzymes with diverse function as well as into enzymes not
belonging to this family, such as TSOX and PDH1.
Phosphate Stabilizes the Bfd Structure. The three Bfd
molecules in the asymmetric unit cell, chains G, H, and I,
exhibit average main chain B-factors 25.8, 64.0, and 29.0 Å2,
respectively (Figure 4a). Despite the higher thermal factors and
absence of electron density between residues 16 and 33 in chain
H (green), the three Bfd chains are structurally similar, as is
evident from the small Cα rmsd from comparing chains G to I
(0.24 Å) and H (0.25 Å) (Figure S2, Supporting Information).
Strong positive Fo − Fc electron density greater than 6σ near
chain G was modeled as a phosphate ion coordinated by the
side chains of R26, R29 and K46 and, via a crystal contact, by
the side chain of K76 from a nearby BfrB (Figure 4b). The
shape of the observed electron density along with the fact that
phosphate was present in the protein storage buﬀer, and
crystallization solution made assignment of phosphate at this
site unambiguous. Phosphate likely mediates otherwise
repulsive interactions of the R26 (α-2), R29 (α-2), and K46
(α-3) side chains and enables their hydrophobic portions to
pack against the Y25 (α-2) side chain and form a network that
stabilizes the short α-2 helix. The phosphate-mediated
stabilization of α-2 may be critical to the integrity of the Bfd
fold and that of the [2Fe-2S] cluster because in its absence, α-2
is likely to unfold and create a long loop stretching from the Nterminus of L2 (Ala15) to the C-terminus of L3 (Ala41) (see
Figure 3a). The proposed stabilizing role of phosphate is in
agreement with three experimental observations: (i) isolation of
recombinant Pa-Bfd can only be carried out in phosphate
buﬀer, (ii) attempts to transfer Pa-Bfd into nonphosphate
buﬀers causes gradual loss of the [2Fe-2S] cluster, and (iii)
crystals of the Pa-BfrB−Bfd complex can only be obtained if
each of the proteins is dissolved in phosphate buﬀer and if the
precipitant contains high phosphate concentrations. Inspection
of crystal contacts also supports this idea (Figure 4c): In Bfd
chains G (magenta spheres) and I (orange spheres) several
crystal contacts aﬀecting R26 and R29 contribute to organize α2. In contrast, chain H (green spheres) does not experience
crystal contacts, which is likely the reason why residues 16−33,
which comprise the C-terminal of α-1, L2, α-2 and the Nterminus of L3, are disordered. It is therefore likely that the
situation observed in chain H most closely represents solution
conditions, where a dynamic on−oﬀ coordination of phosphate
by R26, R29, and K46 prevents large unfolding excursions of α2, in turn maintaining the integrity of the [2Fe-2S] cluster.
To further explore this idea, the structural ﬂuctuations in PaBfd bound to phosphate were compared with the ﬂuctuations
in the structure upon removal of phosphate in silico. A coarsegrained normal-mode analysis was performed for the
phosphate-bound and phosphate-free structures with the aid
of the program Vibe,44 which treats protein structures as an
elastic network of the center of mass of each residue in the
sequence. The calculations suggest that residues C38 (iron
ligand), G39 and K40 in loop L2, and G21 in loop L3 exhibit
ﬂuctuations larger than other residues in the phosphate-bound

Figure 3. The Bfd fold. (a) View of the helix−turn−helix fold of Bfd
(chain G) and associated [2Fe-2S] cluster; Fe and S are shown in
orange and yellow spheres, respectively. (b) Zoomed-in view of the
[2Fe-2S] cluster depicting phased anomalous diﬀerence maps (green
mesh) of the iron ions obtained from diﬀraction data collected at λ =
1.73769 Å, contoured at 8σ. (c) Structural alignment showing how an
equivalent of the Bfd structure (cyan) matches a portion of the
structure (magenta) of the α-subunit of PDH1 (PDB: 1Y56); the rmsd
of common Cα atoms in the alignment is 0.34 Å. (d) Structural
alignment of Bfd with a portion of the N′-terminal domain of CopZNT (PDB: 2HU9); the Zn2+-binding portion has been omitted to
emphasize that the β-hairpin containing Fe ligands C75 and C77, and
subsequent α-helix (magenta) are structurally equivalent to L1
(containing C4 and C6) and α-1 in Pa-Bfd (cyan). The loop−
helix−loop containing C109 and C119 in CopZ-NT (green) is longer
and structurally diﬀerent from L3 in Pa-Bfd, but the Fe ligand C119 is
structurally equivalent to C41 in Pa-Bfd.

observed in a single domain protein. It is interesting, however,
that close matches were observed to a portion of the α-subunit
of heterotetrameric sarcosine oxidase (TSOX) from Corynebacterium sp.,41 to a section of the α-subunit of the
heterooctameric proline dehydrogenase (PDH1) from Pirococcus horikoshii,42 and to the N′-terminal domain of the
chaperone CopZ from Archaeoglobus fulgidus.43
Figure 3c illustrates how an equivalent of the Bfd fold (cyan)
is contained within a relatively small portion of the α-subunit of
PDH1 (magenta); despite the strong structural conservation,
there is no signiﬁcant sequence similarity between the proteins.
CopZ is a two-domain protein member of the Fer2-BFD family
that binds a Zn2+ and a [2Fe-2S] cluster in its N-terminal
domain. Its [2Fe-2S] cluster is bound by four Cys ligands
arranged in a C-X1-C-X31-C-X8-CC motif, which includes the
conserved C-X1-C arrangement. Pa-Bfd and CopZ share 60%
sequence similarity in the stretch ﬂanking the C-X1-C motif
(V2-A17 in Bfd; V74-A88 in CopZ-NT). In CopZ-NT, this
stretch of sequence forms a β-hairpin that contains iron ligands
C75 and C77, which are structurally equivalent to C4 and C6 in
Pa-Bfd and a subsequent α-helix (magenta in Figure 3d). C109
is on a one-turn α-helix (green) in CopZ-NT and therefore is
structurally distinct from C38 in Pa-Bfd, which is part of L3.
C119, on the other hand, is structurally equivalent to C41 in
Pa-Bfd. Consequently, to the best of our knowledge, the
13474
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Figure 4. Phosphate stabilizes the Pa-Bfd fold. (a) Main chain average B-factors in Bfd chains G (magenta), H (green), and I (orange); vertical lines
highlight the Cys ligands, and the gap in the green trace is absent electron density in chain H. (b) Fo − Fc omit map contoured at 6σ (orange mesh)
showing the electron density modeled as phosphate coordinated by the side chains of R26, R29, and K46 in Bfd chain G (cyan); the phosphate is
also coordinated, via a crystal contact, by the side chain of K76 from a nearby BfrB related by the symmetry operator Y, X, −Z + (001). (c) View of
BfrB (gray) and bound Bfd in the asymmetric unit (spheres) showing the crystal contacts (red spheres) experienced by chain G (magenta), H
(green), and I (orange); the phosphate bound to chain G is shown in blue spheres. The crystal contacts aﬀecting chains G and H contribute to
stabilize short helix α-2 and in the case of chain G, a speciﬁc contact from K76 in a nearby BfrB molecule contributes to organize the phosphate ion.
In chain H, which does not experience crystal contacts, helix α-2 and ﬂanking loops L2 and L3 experience conformational disorder. (d) Plot of per
residue mobility in the Bfd−phosphate complex (chain G). Residue mobility is a normalized mean square ﬂuctuation of the residue center of mass
calculated by an elastic network model.44 (e) Plot of the relative change of the mean square ﬂuctuations of Bfd residues upon dissociation of the
Bfd−phosphate complex.

phosphate causes a relatively large increase in the ﬂuctuations
of Y25, R26, and R29 in α-2 and A42 and K46 in α-3 (Figure
4e), consistent with the proposed stabilizing inﬂuence of the
anion on α-2 (Figure 4b).

structure (Figure 4d). Note that phosphate, shown at the end
of the sequence in the plot, is one of the most kinetically active
moieties, which may be indicative of its propensity to be in
dynamic on−oﬀ equilibrium with Pa-Bfd. Removal of
13475
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Figure 5. The Pa-BfrB−Bfd interface. (a,b) Per-residue plot of surface area buried at the complex interface; contributions from residues in Bfd are
shown in cyan, and contributions from residues in the A and B subunits of BfrB are shown in wheat and gray, respectively. Conserved residues are
denoted by (*) and conservative replacements by (:). (c) View of the complex interface showing Bfd in cyan and subunits A and B of BfrB in wheat
and gray, respectively, oxygen in red, nitrogen in blue, sulfur in yellow, and iron in orange. The BfrB surface was rendered semitransparent to show
the side chains forming the cleft at the dimer interface. Note the burial of Bfd side chains Y2, L5, and K40 within the cleft, whereas M1 interacts only
with subunit A of BfrB via hydrophobic and hydrogen-bonding interactions (dotted lines indicate hydrogen-bonding interactions). Iron ligands C6
and C41 also participate at the complex interface, placing the [2Fe-2S] cluster of Bfd in close proximity to the BfrB surface.

The Pa-BfrB−Bfd Interface. A molecule of Bfd binds
between two BfrB subunits resulting in the burial of 607 Å2 at
the complex interface. The identities of residues participating at
the interface and their relative contribution to the buried
surface are shown in Figure 5; the contribution of Bfd residues
to the total buried surface is plotted in Figure 5a, and the
contribution of BfrB residues is plotted in Figure 5b, with
residues from subunit A in wheat and residues from subunit B
in gray. The symbols on top of each bar indicate that a
particular residue is conserved (*) or conservatively replaced
(:) in the amino acid sequence alignments shown in Figure S1,
Supporting Information. It is signiﬁcant that the majority of
residues buried at the complex interface are conserved in the
sequences of both proteins because it strongly suggests that the
structure of the complex is biologically relevant and underscores the notion that binding of Bfd to Bfr is a common
mechanism for the regulation of cytosolic iron in a variety of
Gram negative bacteria.
A zoomed-in view of the interacting surface (Figure 5c)
shows Pa-Bfd (cyan) bound at the interface of two subunits in
Pa-BfrB; subunit A is gray, and subunit B is wheat. Y2, L5, and

K40, three of the four residues with the largest contributions to
the buried Bfd surface, wedge their side chains in a cleft formed
at the interface of each subunit dimer in Pa-BfrB. In
comparison, M1, the fourth Pa-Bfd residue with the largest
contribution to the buried complex interface interacts only with
subunit A via hydrophobic and hydrogen-bond contacts. The
structure of each Pa-BfrB subunit dimer in complex with Pa-Bfd
is very similar to the subunit dimer structure of Pa-BfrB alone;
the average rmsd from comparing main chain and side chain
atoms from Pa-BfrB subunits A and B in the Pa-BfrB−Bfd
complex with equivalent subunits in the structure of Pa-BfrB
alone is 0.14 and 0.67 Å, respectively (see Figure S3,
Supporting Information). The relatively small rearrangements
on the surface of Pa-BfrB upon binding of Pa-Bfd are illustrated
in Figure 6: The view in Figure 6a shows a cleft formed at the
interface of subunits A (wheat) and B (gray) in Pa-BfrB alone.
Binding of Pa-Bfd (cyan) occurs with the burial of the Y2 and
L5 side chains within the cleft and is accompanied by
81
85
reorientation of the L68
B , EA , and EA side chains on Pa-BfrB,
eﬀectively narrowing the cleft to contain the pertinent Pa-Bfd
side chains (Figure 6b). These side chain relocations and those
13476
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Figure 6. Small rearrangements occur on the surface of Pa-BfrB upon
binding Pa-Bfd. (a) Surface representation of a cleft formed at the
subunit−dimer interface in Pa-BfrB (PDB 3IS7) where Pa-Bfd binds.
85
(b) Binding of Pa-Bfd causes side chain rearrangements in E81
A , EA ,
and L68
B which narrow the cleft to accommodate Y2 and L5 from PaBfd. (c) Cartoon representation depicting the structural rearrangements in Pa-BfrB brought about by the binding of Pa-Bfd (cyan). Side
chains in unbound Pa-BfrB (green) rearrange to the conformations
shown by the side chains in wheat (subunit A) and gray (subunit B) in
the Pa-BfrB−Bfd complex. The resultant polar- and hydrogen-bonding
interactions at the complex interface are shown by dashed lines.

aﬀecting D73
B are depicted in the view of Figure 6c to illustrate
that with the exception of L68
B , all the Pa-BfrB side chains that
change orientation upon binding form hydrogen bonding
interactions with Pa-Bfd.
Each heme in Bfr is buried within a subunit dimer, placing
the heme iron ∼18 Å below the Bfr surface and allowing the
heme propionates to reach the interior cavity. Although it has
been determined that the hemes in Bfr mediate electrons from
the surface to the mineral core,10,14 the vast and complex Bfr
surface has made it challenging to identify electron-transfer
paths connecting the surface and the buried heme. The
structure of the BfrB−Bfd complex reveals that the edge-toedge distance between the [2Fe-2S] cluster in Bfd and heme in
BfrB is 15.1 Å. With the aid of the program Harlem45 the
coordinates of the BfrB−Bfd complex were used to calculate
the most probable path for electron transfer, which is likely to
proceed from S2 in the iron sulfur cluster of Pa-Bfd to a heme
vinyl β carbon (CBB) in Pa-BfrB, via conserved residues Q72
B
and L71
B (Figure 7a). A model with inside view of Pa-BfrB
71
(Figure 7b) illustrates how Q72
B and LB in Pa-BfrB (purple)
bridge the iron sulfur cluster of Pa-Bfd located at the complex
interface to the heme (green) buried deep within the Pa-BfrB
structure. The model also shows how the heme propionates
protrude into the interior cavity, suggesting that the iron
mineral may be in intimate contact with the heme propionates,
thus facilitating electron capture and dissolution in the form of
Fe2+.
Functional Signiﬁcance. In the complex, the [2Fe-2S]
cluster of Pa-Bfd is in an ideal position to transfer electrons to
the heme in Pa-BfrB, an observation that strongly supports the
notion that Pa-Bfd promotes the release of Fe2+ from

Figure 7. Binding of Pa-Bfd to Pa-BfrB places the iron sulfur cluster of
Pa-Bfd in an ideal position to transfer electrons to the heme in PaBfrB. (a) The best path for electron transfer predicted by the program
Harlem is from S2 in Pa-Bfd to heme vinyl carbon CBB in Pa-BfrB,
71
including two nonbonding jumps and Q72
B and LB (purple). (b) Inside
view of the Pa-BfrB cavity illustrating the putative path of electron
transfer across the Pa-BfrB protein shell, from Pa-Bfd (cyan) bound at
the Pa-BfrB surface to heme buried below the surface (green) through
71
Q72
B and LB (purple).

bacterioferritin by mediating electrons from Pa-FPR to PaBfrB.10 However, before the model can be ﬁrmly established it
is necessary to consider that in the previous study eﬃcient Fe2+
release was also observed when Pa-BfrB was reconstituted with
Pa-FPR and apo-Pa-Bfd.10 Since the latter is devoid of an iron
sulfur cluster, it was suggested that apo-Bfd may function to
facilitate electron transfer from Pa-FPR to Pa-BfrB perhaps by
recruiting Pa-FPR to the Pa-BfrB surface.10 It is noteworthy,
however, that in the previous study, apo-Bfd was prepared in
situ by incubating Pa-Bfd with dithionite and the iron chelator
2,2′-bipyridine (bipy), so the resultant solution contained iron
and sulﬁde ions. Their presence could have caused spontaneous
reassembly of a [2Fe-2S] cluster in apo-Bfd or redox reactions
that facilitated iron release. Consequently, to understand the
role, if any, of apo-Bfd in aiding iron release from Pa-BfrB, it is
necessary to prepare, isolate, and characterize the apo-protein
for subsequent evaluation of its participation in iron release.
Apo-Bfd was prepared by incubating Pa-Bfd in 8 M urea in
the presence of the iron chelator HBED at pH 5.5. Chelated
iron and sulﬁde were removed by dialysis while maintaining the
13477
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high-energy transition to 201 nm, with R ∼ 0.23 (red),
indicating additional loss of structure. Taken together, the
observations are in good agreement with a stabilizing inﬂuence
of phosphate on the Bfd fold and support the notion that apoBfd is in dynamic equilibrium between an α-helical and a more
disordered structure likely comprised of turns and nascent
helices. Assembly of the [2Fe-2S] cluster shifts the equilibrium
toward the α-helical fold revealed by the Pa-Bfd structure.
Iron release from Pa-BfrB was studied as reported before10
by following the time-dependent formation of [Fe(bipy)3]2+ at
523 nm after addition of excess NADPH to a cuvette
containing the appropriate proteins and excess bipy. Addition
of NADPH to a mixture of BfrB and FPR causes negligible iron
release (Δ in Figure 8c), whereas the presence of Pa-Bfd
promotes rapid and complete release of iron from Pa-BfrB (○).
In contrast, iron release in the presence of apo-Bfd is sluggish
(□ in Figure 8d), demonstrating that apo-Bfd does not
promote the release of iron from BfrB. These observations
suggest that in the previous study when apo-Bfd was prepared
in situ, iron and sulﬁde ions may have assembled into a Bfdbound iron sulfur cluster or into nonprotein clusters capable of
reducing BfrB-iron. In order to emulate the conditions resulting
from preparing apo-Bfd in situ, a cuvette containing a solution
of apo-Bfd, Pa-BfrB, and Pa-FPR was treated with 2 equiv of
Fe2+, 2 equiv of S2−, and excess bipy. Addition of NADPH
promoted rapid iron release from Pa-BfrB (● in Figure 8d),
whereas iron release upon addition of NADPH to a solution of
Pa-BfrB, Pa-FPR, Fe2+, and S2− in the same concentration but
lacking apo-Bfd is sluggish (⧫ in Figure 8d). These
observations suggest that Fe2+ and S2− can assemble into
apo-Bfd to enable reduction of the ferric core mineral and
release of Fe2+ and are consistent with a previous report
showing that a [2Fe-2S] cluster can be assembled into apo-Bfd
in the presence of Fe2+ and S2−.19
We have also obtained additional evidence demonstrating the
participation of the [2Fe-2S] cluster by monitoring its oxidation
state during the reaction with Pa-BfrB in the absence of
reductant (NADPH and FPR): A 30 μM solution of Pa-Bfd in
20 mM phosphate buﬀer pH 7.6 was placed in a cuvette (black
trace in Figure 9a). Treating the Pa-Bfd solution with 0.8 equiv
of sodium dithionite resulted in the nearly featureless UV−vis
spectrum characteristic of a reduced [2Fe-2S] cluster (red
trace). The spectrum remained unchanged for the 15 min it was
monitored before a small volume of a solution containing PaBfrB reconstituted with 590 Fe atoms/BfrB and a small volume
of EDTA solution were added to produce a ﬁnal Pa-BfrB
concentration of 0.08 μM and ﬁnal EDTA concentration of 0.1
mM. The EDTA was added to prevent precipitation of ferrous
phosphate, which also causes protein precipitation and drift of
the spectral baseline. The spectral changes brought by the
addition of Pa-BfrB are shown in Figure 9b: The red trace
corresponds to reduced Pa-Bfd. The blue trace, which was
obtained 20 s after the addition Pa-BfrB, features a Soret band
at 424 nm indicating that the heme in Pa-BfrB is reduced. The
magenta, green, and black traces were obtained 1, 3, and 5 min,
respectively, after the addition of Pa-BfrB; note that the
intensity of peaks characteristic of Pa-Bfd (334 and 465 nm)
increase and reach their maximum intensity at ∼5 min, with
concomitant shift of the Soret band to 418 nm, which indicates
oxidation of the heme in BfrB. To more clearly visualize the
oxidation state of the [2Fe-2S] cluster of Pa-Bfd in the resultant
solution, a diﬀerence spectrum was obtained by subtracting a
spectrum of 0.08 μM Pa-BfrB from the black trace (5 min) in

apo-protein in an unfolded state, and the apo-Bfd was then
refolded by dialysis against phosphate buﬀer. The molecular
mass of isolated apo-Bfd (7807 ± 1 Da) measured by mass
spectrometry is identical to the value calculated from the
sequence, including the initiator Met. The UV−vis spectrum of
apo-Bfd shows only a 280 nm band and is clearly distinct from
the spectrum of Pa-Bfd, which displays ligand-to-metal chargetransfer transitions in the visible region (Figure 8a). The far UV

Figure 8. A [2Fe-2S] cluster in Pa-Bfd is necessary to promote Fe2+
mobilization from Pa-BfrB. (a) UV−vis spectra of Pa-Bfd (black) in 50
mM potassium phosphate pH 7.0, 150 mM NaCl, 5 mM DTT, and
apo-Bfd (red) in 200 mM potassium phosphate pH 7.0 and 5 mM
TCEP. (b) Far UV CD spectra of: (blue) Pa-Bfd in 50 mM potassium
phosphate pH 7.0, 4 mM NaCl, and 0.13 mM DTT showing double
minima at 208 and 222 nm; (black) apo-Bfd in 200 mM potassium
phosphate pH 7.0, 1 mM TCEP with a minimum at 203 nm, and a
shoulder at 222 nm; (red) apo-Bfd in 200 mM Tris, pH 7.0, 120 mM
NaCl, and 1 mM TCEP with a minimum at 201 nm and a shoulder at
223 nm. (c) Time-dependent increase of normalized ΔA523 upon
addition of excess NADPH (ﬁnal concentration 1.5 mM) to 20 mM
phosphate buﬀer (pH 7.6) containing: (Δ) Pa-BfrB (0.25 μM) and
Pa-FPR (10 μM), and (○) Pa-BfrB (0.25 μM), Pa-FPR (10 μM), and
Pa-Bfd (10 μM). (d) Time-dependent increase of normalized ΔA523
upon addition of excess NADPH to a solution containing: (□) PaBfrB (0.25 μM), Pa-FPR (10 μM), and apo-Pa-Bfd (10 μM); (●) PaBfrB (0.25 μM), Pa-FPR (10 μM), apo-Pa-Bfd (10 μM), (NH4)2Fe(SO4)2 (20 μM), and Na2S (20 μM); and (⧫) Pa-BfrB (0.25 μM), PaFPR (10 μM), (NH4)2Fe(SO4)2 (20 μM), and Na2S (20 μM). ΔA523
was normalized to the absorbance value expected upon removal of all
iron ions in Pa-BfrB.

CD spectrum of Pa-Bfd, with double minima at 208 and 222
nm and [θ]222/[θ]208 = R ∼ 1.1 (blue in Figure 8b), is typical of
α-helical peptides and consistent with the Bfd fold. In
comparison, the spectrum of apo-Bfd in phosphate buﬀer
shows minima at 222 and 203 nm, with R = 0.45 (black). The
blue shift of the high-energy band and decrease in intensity of
the 222 nm transition suggest partial loss of α-helical
structure46 upon removal of the [2Fe-2S] cluster. If phosphate
is removed by dialysis against Tris buﬀer, the CD spectrum of
apo-Bfd shows lower [θ]222 and additional blue shift of the
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is highly unlikely that ferritin mineral is indiscriminately
reduced in vivo. The delivery of electrons to eukaryotic ferritins
from NADH or NADPH is thought to be carried out by ﬂavinor xanthine-containing oxidoreducateses.47 The identity of
these enzymes, however, remains unknown. For this reason,
studies directed at probing iron release from ferritin-like
molecules have utilized a wide range of reductants, including
dithionite, thiols, ascorbate, diphenols dihydroﬂavins, and
diphenols, to drive the release of iron from ferritin and
ferritin-like molecules.7,14,48−51 Although these studies have
provided important insights, the signiﬁcance of molecular
recognition and protein−protein interactions in the control of
iron release from ferritin and ferritin-like molecules has
remained mysterious. The identiﬁcation of bfd genes
contiguous to bf r genes in E. coli11,18 and in P. aeruginosa10,19
and their diﬀerential regulation under conditions of low iron
stress20,21 provided the impetus to demonstrate that Pa-Bfd
enables iron release from Pa-BfrB.10 The manner of Bfd
participation in the process, however, was not clear since PaBfd, or its apo-form prepared in situ, were found to accelerate
iron release. The highly speciﬁc Pa-BfrB−Bfd interface reported
here strongly supports the notion that in vivo Pa-Bfd mediates
electrons to Pa-BfrB. In addition, experiments with Pa-Bfd and
its apo-form allowed us to unambiguously demonstrate that
only Pa-Bfd promotes the release of iron from Pa-BfrB.
Consequently, the structure of the Pa-BfrB−Bfd complex
enables, for the ﬁrst time, structural insight into the control
exerted by molecular recognition on the mobilization of iron
from a ferritin-like molecule and the electron paths that enable
electrons to traverse the Bfr shell and reduce ferric mineral in
the Bfr cavity (Figure 7). Given that iron storage proteins in
bacteria are essential for the survival of pathogens in the host,15
the insights obtained from the Pa-BfrB−Bfd complex and its
function in maintaining bacterial iron homeostasis may help in
the future development of therapeutic strategies to treat
bacterial infections. In this context, it is important that residues
at the Pa-BfrB−Bfd interface are conserved in Bfr and Bfd
sequences from a number of bacteria (Figure 5 and Figure S1,
Supporting Information). Moreover, the bf r and bfd genes
coding for the Bfrs and Bfds aligned in Figure S1 are adjacent to
one another (Table S1, Supporting Information), suggesting
that the clustering of the bfd (PA3530) and bf rB (PA3531)
genes in P. aeruginosa is common to a wide number of bacterial
species. Consequently, the speciﬁc recognition and binding that
is necessary to release iron from bacterioferritin are likely a
mechanism of widespread signiﬁcance to the understanding of
bacterial iron homeostasis.

Figure 9. (a) (black) UV−vis spectra of oxidized 30 μM Pa-Bfd in 20
mM potassium phosphate pH 7.6. (red) Spectrum of reduced Pa-Bfd
obtained upon addition of 0.8 equiv of sodium dithionite relative to
oxidized Pa-Bfd. (b) Spectral changes upon addition of Pa-BfrB (0.08
μM ﬁnal concentration) reconstituted with 590 Fe atoms/BfrB to
reduced Pa-Bfd: (red) spectrum prior to the addition of Pa-BfrB;
(blue) 20 s, (magenta) 1 min, (green) 3 min, and (black) 5 min after
the addition of Pa-BfrB. An increase in the intensity at 334 and 465
nm indicates reoxidation of Pa-Bfd. (c) (red) diﬀerence spectrum
obtained from subtracting a spectrum obtained from 0.08 μM Pa-BfrB
from the black trace spectrum (5 min) in (b). The diﬀerence spectrum
is nearly identical to the spectrum of oxidized 30 μM (black trace).
The addition of EDTA ﬁnal concentration 0.1 mM immediately prior
to the addition of Pa-BfrB was necessary to prevent formation of
insoluble ferrous phosphate, which caused protein precipitation and
drift in the baseline of the spectra. (d) Time-dependent formation of
[Fe(bipy)3]2+ upon addition of excess bipy (3 mM) and Pa-BfrB (0.08
μM) to a solution of Pa-Bfd reduced as in (a). The maximum
concentration of [Fe(bipy)3]2+ formed (normalized to the initial
volume) is ∼24 μM and equivalent to the concentration of Pa-Bfd
obtained by reducing 30 μM Pa-Bfd with 0.8 equiv of dithionite.

Figure 9b. The diﬀerence spectrum (red in Figure 9c) is
virtually identical to the spectrum obtained from the solution
containing 30 μM oxidized Pa-Bfd (black trace in Figures 9a
and 9c). To correlate these observations to iron release from
Pa-BfrB, a similar experiment was conducted, except that the
solution containing reduced Pa-Bfd was made 3 mM in bipy
immediately prior to the addition of Pa-BfrB (no EDTA was
needed). This allowed us to observe the time dependentformation of Fe2+ detected at 523 nm, in the form of
[Fe(bipy)3]2+ (Figure 9d). Note that the maximum concentration of [Fe(bipy)3]2+ formed is ∼24 μM, a value that is
equivalent to the concentration of reduced Pa-Bfd obtained
upon addition of 0.8 equiv of dithionite to the solution 30 μM
in Pa-Bfd. Clearly, these observations are in good agreement
with the notion that the heme in Pa-BfrB mediates electrons
between the [2Fe-2S] cluster in Pa Bfd and the iron core in PaBfrB to promote release of Fe2+.
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Coordinates and structure factors have been deposited to the
Protein Databank with accession code 4E6K. Amino acid
sequence alignments of Bfd and Bfr sequences; superposition of
Pa-Bfd chains in the asymmetric cell unit of the Pa-BfrB−Bfd
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CONCLUDING REMARKS
Although the recovery of Fe2+ from the ferritin cavity requires
that electrons traverse the protein shell and reach the mineral, it
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